Rafferty Asset Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.14 - $2.09 $558,936 - $1.02 Million	-490,295 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$1.67 - $2.76 $406,832 - $672,369	243,612 Added 98.76%	490,295 $956,000
Q3 2021 Nov 10, 2021	BUY	$2.62 - $3.45 $646,309 - $851,056	246,683 New	246,683 $676,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.